|
2. Pathology of fibrosis in Crohn's disease - contribution to understanding its pathogenesisNina Zidar, Cord Langner, Miha Jerala, Emanuela Boštjančič, David Drobne, Aleš Tomažič, 2020, original scientific article Keywords: Crohn's disease, fibrosis, stenosis, pathology, pathogenesis
Full text (file, 2,76 MB) This document has more files! More... |
3. Expression of cytokine-coding genes BMP8B, LEFTY1 and INSL5 could distinguish between ulcerative colitis and Crohn's diseaseDaša Jevšinek Skok, Nina Hauptman, Miha Jerala, Nina Zidar, 2021, original scientific article Keywords: inflammatory bowel disease, ulcerative colitis, Crohn's disease, inflammatory cytokines, expression, bioinformatics approach, experimental validation
Full text (file, 2,54 MB) This document has more files! More... |
4. Expression of fibrosis-related genes in liver and kidney fibrosis in comparison to inflammatory bowel diseasesMiha Jerala, Nina Hauptman, Nika Kojc, Nina Zidar, 2022, original scientific article Keywords: inflammatory bowel diseases, fibrosis, Crohn’s disease, ulcerative colitis, gene expression
Full text (file, 1,24 MB) This document has more files! More... |
5. Multiple switches from the originator infliximab to biosimilars is effective and safe in inflammatory bowel diseaseJurij Hanžel, Jeroen M. Jansen, Rinze W. F. ter Steege, Krisztina B. Gecse, Geert R. D'Haens, 2022, original scientific article Keywords: SB2, CT-P13, multiple switches, Crohn's disease, inflammatory bowel disease, ulcerative colitis, adults, feces, c-reactive protein, infliximab, adverse event, leukocyte l1 antigen complex, infusion procedures, biosimilar pharmaceuticals, disease remission, imputation, antidrug antibody, infliximab-dyyb
Full text (file, 608,73 KB) This document has more files! More... |
6. Pharmacokinetic-pharmacodynamic model of vedolizumab for targeting endoscopic remission in patients with Crohn diseaseJurij Hanžel, Erwin Dressen, Séverine Vermeire, Mark Löwenberg, Frank Hoentjen, Peter Bossuyt, Esmé Clasquin, Filip J. Baert, Geert R. D'Haens, Ron Mathôt, 2022, original scientific article Keywords: therapeutic drug monitoring, exposure-response, pharmacometrics, inflammatory bowel disease, Crohn's disease, drug clearance, endoscopy, pharmacodynamics, infusion procedures, disease remission, vedolizumab, therapy
Full text (file, 2,05 MB) This document has more files! More... |
7. Oxidative stress-related biomarkers as promising indicators of inflammatory bowel disease activityArmando Tratenšek, Igor Locatelli, Iztok Grabnar, David Drobne, Tomaž Vovk, 2024, original scientific article Keywords: inflammatory bowel disease, ulcerative colitis, Crohn's disease, oxidative stress, biomarker, meta-analysis
Full text (file, 5,83 MB) This document has more files! More... |
8. Fibrosis-related microRNAs in Crohn’s disease with fibrostenosis and inflammatory stenosisMiha Jerala, Tinkara Remic, Nina Hauptman, Nina Zidar, 2024, original scientific article Keywords: Crohn’s disease, fibrostenosis, inflammatory stenosis, fibrosis, miRNA
Full text (file, 1,36 MB) This document has more files! More... |
